首页|期刊导航|中国体外生命支持|静脉-动脉体外膜氧合治疗急性心肌梗死合并心源性休克患者的预后影响因素分析

静脉-动脉体外膜氧合治疗急性心肌梗死合并心源性休克患者的预后影响因素分析OA

Prognostic Factors Associated With Veno-Arterial Extracorporeal Membrane Oxygenation in Patients With Acute Myo-cardial Infarction Complicated by Cardiogenic Shock

中文摘要英文摘要

目的 分析静脉-动脉体外膜氧合(V-A ECMO)治疗急性心肌梗死合并心源性休克(AMI-CS)患者的短期预后影响因素,构建早期风险预测模型,为临床干预时机与个体化支持策略提供参考.方法 回顾性纳入2021年1月至2024年12月在本中心接受V-A ECMO治疗的AMI-CS患者112例,收集其一般资料、实验室参数、器官功能评分、机械辅助使用情况及临床结局.主要结局为28 d内死亡,次要结局包括ECMO撤机成功率、ICU 停留时间及并发症发生率.采用单因素与多因素Logistic回归分析筛选影响28 d死亡的独立危险因素,构建联合预测模型并通过受试者工作特征(ROC)曲线评估其判别能力.结果 共纳入112例患者,男性占71.43%(80/112),平均年龄为(62.8±9.4)岁.28 d死亡率为58.93%(66/112),撤机成功率为41.07%(46/112).死亡组与生存组在ECMO前乳酸水平[(6.18±2.21)mmol/L vs.(4.03±1.65)mmol/L,P<0.001]、肌酐[(135.7±44.6)μmol/L vs.(104.2±38.1)μmol/L,P=0.002]、N末端脑钠肽前体(NT-proBNP)[(15 836.3±7 642.5)ng/L vs.(10 128.5±6 284.7)ng/L,P=0.009]、序贯器官衰竭评估(SOFA)评分[(10.6±3.1)分 vs.(8.4±2.6)分,P<0.001]及主动脉内球囊反搏(IABP)联合使用率(43.94%vs.67.39%,P=0.018)方面差异显著.多因素Logistic回归显示,乳酸水平(OR=1.412,95%CI:1.136~1.755,P=0.002)、NT-proBNP水平(OR=1.302,95%CI:1.071~1.684,P=0.003)、SOFA评分(OR=1.239,95%CI:1.045~1.470,P=0.014)及未联合IABP(OR=2.231,95%CI:1.057~4.708,P=0.035)为28 d死亡的独立危险因素.ROC分析显示,乳酸、NT-proBNP及SOFA评分的曲线下面积(AUC)分别为0.772、0.704、0.756,三者联合预测模型的AUC提高至0.842(95%CI:0.763~0.921),灵敏度为85.5%,特异度为80.4%.结论 V-A ECMO支持下AMI-CS患者的短期死亡率仍较高,ECMO前乳酸、NT-proBNP、SOFA评分及IABP联合使用情况为重要预后因素.基于多因素构建的预测模型具有良好判别力,有助于早期识别高危患者并指导临床个体化干预策略.

Objective To identify short-term prognostic factors in patients with acute myocardial infarction compli-cated by cardiogenic shock(AMI-CS)receiving venoarterial extracorporeal membrane oxygenation(V-A ECMO)support,and to develop an early risk prediction model to guide clinical decision-making and individualized management strategies.Methods A total of 112 AMI-CS patients who received V-A ECMO support at our center from January 2021 to December 2024 were retrospectively enrolled.Demographic data,laboratory findings,organ function scores,mechanical circulatory sup-port status,and clinical outcomes were collected.The primary endpoint was 28-day all-cause mortality.Univariate and mul-tivariate logistic regression analyses were performed to identify independent predictors of 28-day mortality.A composite risk prediction model was constructed and evaluated using receiver operating characteristic(ROC)curve analysis.Results Among the 112 patients enrolled,71.43%were male(80/112),and the mean age was 62.8±9.4 years.The 28-day mortality rate was 58.93%(66/112),and the successful weaning rate from ECMO was 41.07%(46/112).Compared with survivors,non-survivors had significantly higher baseline lactate levels(6.18±2.21 vs.4.03±1.65 mmol/L,P<0.001),serum creatinine(135.7±44.6 vs.104.2±38.1 μmol/L,P=0.002),NT-proBNP levels(15 836.3±7 642.5 vs.10 128.5±6 284.7 ng/L,P=0.009),and SOFA scores(10.6±3.1 vs.8.4±2.6,P<0.001),along with a lower rate of intra-aortic balloon pump(IABP)use(43.94%vs.67.39%,P=0.018).Multivariate logistic regression revealed that elevated lactate(OR=1.412,95%CI:1.136-1.755,P=0.002),higher NT-proBNP(OR=1.302,95%CI:1.071-1.684,P=0.003),increased SOFA score(OR=1.239,95%CI:1.045-1.470,P=0.014),and absence of IABP support(OR=2.231,95%CI:1.057-4.708,P=0.035)were independent predictors of 28-day mortality.ROC curve analysis demonstrated that lactate,NT-proBNP,and SOFA score yielded AUCs of 0.772,0.704,and 0.756,respective-ly.The combined prediction model showed improved discriminative performance,with an AUC of 0.842(95%CI:0.763-0.921),sensitivity of 85.5%,and specificity of 80.4%.Conclusion AMI-CS patients supported by V-A ECMO have a high short-term mortality.Baseline lactate,NT-proBNP,SOFA score,and IABP use are important prognostic indicators.A multifactorial predic-tion model based on these variables demonstrates good discriminatory power and may aid in early risk stratification and individu-alized clinical decision-making.

邓小明;何霁云;陈宝

成都市第一人民医院心血管内科,成都 610000成都市第一人民医院心血管内科,成都 610000成都市第一人民医院心血管内科,成都 610000

静脉-动脉体外膜氧合急性心肌梗死心源性休克预后分析

veno-arterial extracorporeal membrane oxygenationacute myocardial infarctioncardiogenic shockprog-nostic analysis

《中国体外生命支持》 2026 (1)

18-24,7

10.13498/j.cnki.chin.j.ecls.2026.01.04

评论